Founded in 1927 and headquartered in Warsaw, Indiana, USA, Zimmer Biomet is a global leader in musculoskeletal healthcare. We design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products.
We collaborate with healthcare professionals around the globe to advance the pace of innovation. Our products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Together with healthcare professionals, we help millions of people live better lives.
For the Zimmer GmbH European Headquarters Office in Zug, Switzerland we are looking for a
Compliance Director (100%)
Responsibilities are to provide compliance analysis and advise related to the Zimmer Biomet Corporate Compliance Program (CCP) in EMEA and enhancements thereto and to execute and manage process improvement and infrastructure development for the CCP and related functions. Active participation and lead of Committees and Compliance sub-regions. Further responsibilities are conduct and support on-site employee and third party Compliance training and monitoring as well as tracking functions. The Compliance Director deputizes for the EMEA Compliance Office in managing and supervising the EMEA Compliance Office staff.
Willingness to travel up to 5%.
This is a unique opportunity to develop your international experience and be a part of a truly global team. Zimmer Biomet offers a wide range of challenging career advancement opportunities and dynamic work environment. We look forward to receiving your complete application online.
For this position we accept direct applications only.
Zimmer GmbH
Human Resources
Zählerweg 4
6300 Zug
Phone +41 (0) 58 854 8181
[Close][Email a friend](Please note: this link will open the page in a new browser window.)[Print][Apply for requisition](Please note: this link will open the page in a new browser window.)TwitterLinkedInFacebookAddThismore